Summary of Purpose
intravenous rt-PA is effective to reduce the risk of death or dependency after ischaemic stroke. This effect is due to an early recanalization secondary to the lysis of the clot. However this effect may be counterbalanced by the increased risk of bleeding and also the neurotoxicity of rt-PA, which has been shown in animals to depend on the ratio single chain (sc) / double chain (tc) in the rt-PA administered. The...Read More →
The following dates are available for this trial. Trial information last updated on 18 December 2014.
|1 Nov 2011||23 Apr 2012||1 Nov 2014||1 Dec 2014||1 Dec 2014||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Observation: Cohort
- Perspective: Prospective
- Sampling: Probability Sample